293 [HEK-293] 人胚腎細(xì)胞
Catalogue No.: C028
Product Format: a T25 flask
Culture Properties：貼壁
Complete Growth Medium: 89%H-DMEM+10%FBS+1%雙抗
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Application: Cells and cancer research
NOTE: FOR RESEARCH USE ONLY.

Components

During toripalimab treatment, immune-related adverse events (irAE) including dermatologic, pulmonary, cardiac, endocrine, gastrointestinal, hepatobiliary and renal toxicities, as well as other general symptoms such as fatigue and appetite loss were recorded (Supplementary Table 1) (19). No patients developed any Grade 3-4 irAE. Only 1 patient